Mechanisms of bombesin on growth of gastrinoma (PT) in vivo

Digestive Diseases and Sciences

Volumn 41, Issue 11, 1996, Pages 2180-2186

  Chu, Kyo U ^b   Ishizuka, Jin ^b   Battey, James F ^b   Uchida, Tatsuo ^b   Beauchamp, R Daniel ^b   Townsend Jr , Courtney M ^a   Thompson, James C ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NONE

Author keywords

Bombesin; Gastrin; Gastrinoma; Growth

Indexed keywords

BOMBESIN; BOMBESIN[6-13][6 DEXTRO PENTAFLUOROPHENYLALANINE 11 DEXTRO ALANINE] METHYL ESTER; GASTRIN RELEASING PEPTIDE; MESSENGER RNA; NEUROMEDIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GASTRINOMA; GROWTH; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; ZOLLINGER ELLISON SYNDROME;

EID: 0029803696     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02071398     Document Type: Article

References (49)

1. Jensen RT, Gardner JD: Gastrinoma. In The Pancreas Biology, Pathology and Disease. VLW Go, EP Dimagno, JD Gardner, E Lebrathal, HA Reben, GA Scheele (eds). New York, Raven Press, 1993, pp 931-978
2. Zollinger RM, Ellison EH: Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142:709-728, 1955
3. Townsend CM Jr, Thompson JC: Gastrinoma. Semin Surg Oncol 6:91-97, 1990
4. Modlin IM, Lewis JJ, Ahlman H, Bilchik AJ, Kumar RR: Management of unresectable malignant endocrine tumors of the pancreas. Surg Gynecol Obstet 176(5):507-518, 1993
5. Eriksson B, Öberg K: An update of the medical treatment of malignant endocrine pancreatic tumors. Acta Oncol 32(2):203-208, 1993
6. Mozell E, Woltering EA, O'Dorisio TM, Fletcher WS, Sinclair AJ, Hill D: Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome. Surg Gynecol Obstet 170(6):476-484, 1990
7. Arnold R, Benning R, Neuhaus C, Rolwage M, Trautmann ME: Gastroenteropancreatic endocrine tumours: effect of sandostatin on tumour growth. The German Sandostatin Study Group. Digestion 54(1):72-75, 1993
8. Arnold R, Neuhaus C, Benning R, Schwerk WB, Trautmann ME, Joseph K, Bruns C: Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors. World J Surg 17(4):511-519, 1993
9. Maton PN: Use of octreotide acetate for control of symptoms in patients with islet cell tumors. World J Surg 17(4):504-510, 1993
10. Ellison EC, O'Dorisio TM, Sparks J, Mekhjian HS, Fromkes JJ, Woltering EA, Carey LC: Observations on the effect of somatostatin analog in the Zollinger-Ellison syndrome: Implications for the treatment of apudormas. Surgery 100:437-444, 1986
11. Upp JR Jr, Trudel JL, Townsend CM Jr, Alexander RW, Rajaraman S, Nealon WH, Greeley GH Jr, Thompson JC: Establishment of a human gastrinoma in nude mice. Surgery 104:1037-1045, 1988
12. Chung DH, Evers BM, Beauchamp RD, Upp JR Jr, Rajaraman S, Townsend CM Jr, Thompson JC: Bombesin stimulates growth of human gastrinoma. Surgery 112:1059-1065, 1992
13. Anastasi A, Erspamer V, Bucci M: Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27:166, 1971
14. Alexander RW, Upp JR Jr, Poston GJ, Gupta V, Townsend CM Jr, Thompson JC: Effects of bombesin on growth of human small cell lung carcinoma in vivo. Cancer Res 48:1439-1441, 1988
15. Qin Y, Ertl T, Cai R-Z, Halmos G, Schally AV: Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res 54:1035-1041, 1994
16. Hajri A, Balboni G, Koenig M, Garaud J-C, Damgé C: Gastrin-releasing peptide: In vivo and in vitro growth effects on an acinar pancreatic carcinoma. Cancer Res 52:3726-3732, 1992
17. Avis I, Jett M, Kasprzyk PG, Cuttitta F, Treston AM, Maneckjee R, Mulshine JL: Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan). Mol Carcinogen 8:214-220, 1993
18. Narayan S, Guo Y-S, Townsend CM Jr, Singh P: Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro. Cancer Res 50:6772-6778, 1990
19. Farre A, Ishizuka J, Gomez G, Parekh D, Koo J-Y, Townsend CM Jr, Thompson JC: Bombesin stimulates growth of colon cancer in mice and decreases their survival. Surg Oncol 2:169-173, 1993
20. Radulovic S, Miller G, Schally AV: Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res 51:6006-6009, 1991
21. Yano T, Pinski J, Groot K, Schally AV: Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res 52:4545-4547, 1992
22. 6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160. Prostate 20:269-280, 1992
23. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823-826, 1985
24. Coy DH, Jensen RT, Jiang NY, Lin LT, Bogden AE, Moreau JP: Systematic development of bombesin/gastrin-releasing peptide antagonists. Monogr Natl Cancer Inst 13:133-139, 1992
25. Jensen RT, Mrozinski JE Jr, Coy DM: Bombesin receptor antagonists: Different classes and cellular basis of action. Recent Results Cancer Res 129:87-113, 1993
26. Battey JF, Way JM, Corjay MH, Shapira H, Kusano K, Harkins R, Wu JM, Slattery T, Mann E, Feldman RI: Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc Natl Acad Sci USA 88:395-399, 1991
27. Corjay MH, Dobrzansk DJ, Way JM, Viallet J, Shapira H, Worland P, Sausville EA, Battey JF: Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J Biol Chem 266:18771-18779, 1991
28. Sehrenck TV, Heinz-Grian P, Moran T, Mantey SA, Gardner JD, Jensen RT: Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am J Physiol 256:G747-G758, 1989
29. Coy DH, Mungan Z, Rossowski WJ, Cheng BL, Lin J-T, Mrozinski JE, Jensen RT: Development of a potent bombesin receptor antagonist with prolonged in vivo inhibiting activity on bombesin-stimulated amylase and protein release in the rat. Peptides 13:775-781, 1992
30. DuVal JW, Saffouri B, Weir GC, Walsh JH, Arimura A, Makhlouf GM: Stimulation of gastrin and somatostatin secretion from the isolated rat stomach by bombesin. Am J Physiol 241:G242-G247, 1981
31. Schumbert ML, Saffouri B, Walsh JH, Makhlouf GM: Inhibition of neurally mediated gastrin secretion by bombesin antiserum. Am J Physiol 248:G456-G462, 1981
32. Remy-Heintz N, Perrier-Meissonnier S, Nonotte I, Laliberté M-F, Chevillard C, Laboisse C, Bali J-P: Evidence for autocrine growth stimulation by a gastrin/CCK-like peptide of the gastric cancer HGT-1 cell line. Mol Cell Endocrinol 93:23-29, 1993
33. Beauchamp RD, Townsend CM Jr, Singh P, Glass EJ, Thompson JC: Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice. Ann Surg 202:303-309, 1985
34. Kochman ML, DelValle J, Dickinson CJ, Boland CR: Post translational processing of gastrin in neoplastic human colonic tissues. Biochem Biophys Res Commun 189:1165-1169, 1992
35. Smith JP, Kramer ST, Demers LM: Effects of gastrin and difluoromethylornithine on growth of human colon cancer. Dig Dis Sci 38:520-528, 1993
36. Gullino PM, Ediger RD, Giovanella B, Merchant B, Outzen HC Jr, Reed ND, Wortis HH: Guide for the care and use of the nude (thymus-deficient) mouse in biomedical research. ILAR News 19:M1-M20, 1976
37. Burton K: A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonuclei acid. Biochemistry J 62:315-323, 1956
38. Greeley GH Jr, Thompson JC: Insulinotropic and gastrin-releasing action of gastrin-releasing peptide (GRP). Regul Pept 8:97-103, 1984
39. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
40. Evers BM, Beauchamp RD, Ishizuka J, Townsend CM Jr, Alam T, Papaconstantinou J, Thompson JC: Post transcriptional regulation of neurotension in the gut. Surgery 110:247-252, 1991
41. Cardona C, Rahhitts PH, Spindel ER, Ghatei MA, Blechen NM, Bloom SR, Reeve JG: Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines. Cancer Res 51(19):5205-5211, 1991
42. Moody TW, Staley J, Zia F, Coy DH, Jensen RT: Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines. J Pharmacol Exp Ther 263(1):311-317, 1992
43. Dobrzanski D, Sharoni Y, Wada E, Battey J, Sausville E: Neuromedin-B receptor transfected BALB/3T3 cells: signal transduction and effects of ectopic receptor expression on cell growth. Regul Pept 45:341-352, 1993
44. Alexander RW, Upp JR Jr, Poston GJ, Townsend CM Jr, Singh P, Thompson JC: Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice. Pancreas 3:297-302, 1988
45. Hoosein NM, Kiener PA, Curry RC, Brattain MG: Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res 186:15-21, 1990
46. Gower WR Jr, Ellison EC, Knierim TH, Elkhammas EA, O'Dorisio TM, Fabri PJ: Gastrinoma in vitro: morphological and physiological studies of primary cell cultures. Gastroenterology 98:936-954, 1990
47. Gower WR Jr, Buzogany JA Jr, Ellison EC, Knierim TH, Fabri PJ: Control of gastrin release in cultured gastrinoma-derived G cells. Surgery 104:424-430, 1988
48. Frucht H, Howard JM, Slaff JI, Wank SA, McCarthy DM, Maton PN, Vinayek R, Gardner JD, Jensen RT: Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: A prospective study. Ann Intern Med 111:713-722, 1989
49. McGuigan JE, Wolfe MM: Secretin injection test in the diagnosis of gastrinoma. Gastroenterology 79:1324-1331, 1980